The satiety-promoting action of oleoylethanolamide (OEA) has been associated to the indirect activation of selected brain areas, such as the nucleus of the solitary tract (NST) in the brainstem and the tuberomammillary (TMN) and paraventricular (PVN) nuclei in the hypothalamus, where noradrenergic, histaminergic and oxytocinergic neurons play a necessary role. Visceral ascending fibers were hypothesized to mediate such effects. However, our previous findings demonstrated that the hypophagic action of peripherally administered OEA does not require intact vagal afferents and is associated to a strong activation of the area postrema (AP). Therefore, we hypothesized that OEA may exert its central effects through the direct activation of this ci...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Oleylethanolamide (OEA) is a natural analogue of the endogenous cannabinoid anandamide. Like anandam...
The satiety-promoting action of oleoylethanolamide (OEA) has been associated to the indirect activat...
The anandamide monounsaturated analogue oleoylethanolamide (OEA) acts as satiety signal released fro...
Background: Eating behaviour is regulated by a lot of signals that are produced in the gastrointesti...
Oleoylethanolamide (OEA) is a biologically active lipid amide that is released by small-intestinal e...
Oleoylethanolamide (OEA) is a biologically active lipid amide that is released by small-intestinal e...
Oleoylethanolamide (OEA) is a gut-derived endogenous lipid that stimulates vagal fibers to induce sa...
Key factors driving eating behavior are hunger and satiety, which are controlled by a complex interp...
Chronic exposure to a diet rich in fats changes the gastrointestinal milieu and alters responses to ...
Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of h...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Oleylethanolamide (OEA) is a natural analogue of the endogenous cannabinoid anandamide. Like anandam...
The satiety-promoting action of oleoylethanolamide (OEA) has been associated to the indirect activat...
The anandamide monounsaturated analogue oleoylethanolamide (OEA) acts as satiety signal released fro...
Background: Eating behaviour is regulated by a lot of signals that are produced in the gastrointesti...
Oleoylethanolamide (OEA) is a biologically active lipid amide that is released by small-intestinal e...
Oleoylethanolamide (OEA) is a biologically active lipid amide that is released by small-intestinal e...
Oleoylethanolamide (OEA) is a gut-derived endogenous lipid that stimulates vagal fibers to induce sa...
Key factors driving eating behavior are hunger and satiety, which are controlled by a complex interp...
Chronic exposure to a diet rich in fats changes the gastrointestinal milieu and alters responses to ...
Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of h...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Oleylethanolamide (OEA) is a natural analogue of the endogenous cannabinoid anandamide. Like anandam...